Director/PDMR Shareholding
December 01 2010 - 11:18AM
UK Regulatory
TIDMHIK
RNS Number : 2118X
Hikma Pharmaceuticals Plc
01 December 2010
Annex DTR3
Notification of Transactions of Directors/Persons Discharging Managerial
Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters
+-------------------------------+----------------------------+------------------------------------+---------------------------+
| 1. | Name of the Issuer: | 2. | State whether the |
| | | | notification relates to |
| | Hikma Pharmaceuticals PLC | | (i) a transaction |
| | | | notified in accordance |
| | | | with DTR 3.1.2 R, (ii) a |
| | | | disclosure made in |
| | | | accordance with LR |
| | | | 9.8.6R(1) or (iii) a |
| | | | disclosure made in |
| | | | accordance with section |
| | | | 793 of the Companies Act |
| | | | (2006): |
| | | | DTR 3.1.2 R |
+-------------------------------+----------------------------+------------------------------------+---------------------------+
| 3. | Name of person | 4. | State whether |
| | discharging managerial | | notification relates to a |
| | responsibilities/director: | | person connected with a |
| | Samih Darwazah, Said | | person discharging |
| | Darwazah, Mazen Darwazah | | managerial |
| | and Ali Al-Husry | | responsibilities/ |
| | | | director named in 3 and |
| | | | identify the connected |
| | | | person: |
| | | | Yes: Darhold Limited |
+-------------------------------+----------------------------+------------------------------------+---------------------------+
| 5. | Indicate whether the | 6. | Description of shares |
| | notification is in | | (including class), |
| | respect of a holding of | | debentures or derivatives |
| | the person referred to in | | or financial instruments |
| | 3 or 4 above or in | | relating to shares: |
| | respect of a | | Ordinary Shares |
| | non-beneficial interest: | | |
| | Beneficial interest | | |
| | Darhold Limited | | |
+-------------------------------+----------------------------+------------------------------------+---------------------------+
| 7. | Name of registered | 8. | State the nature of the |
| | shareholders(s) and, if | | transaction: |
| | more than one, the number | | Disposal of Ordinary |
| | of shares held by each of | | Shares |
| | them: | | |
| | BNP Paribas Securities | | |
| | Services account for an | | |
| | on behalf of Credit | | |
| | Suisse AG | | |
+-------------------------------+----------------------------+------------------------------------+---------------------------+
| 9. | Number of shares, | 10. | Percentage of issued |
| | debentures or financial | | class acquired (treasury |
| | instruments relating to | | shares of that class |
| | shares acquired: | | should not be taken into |
| | N/A | | account when calculating |
| | | | percentage): |
| | | | N/A |
+-------------------------------+----------------------------+------------------------------------+---------------------------+
| 11. | Number of shares, | 12. | Percentage of issued |
| | debentures or financial | | class disposed (treasury |
| | instruments relating to | | shares of that class |
| | shares disposed: | | should not be taken into |
| | 310,024 | | account when calculating |
| | | | percentage): |
| | | | 0.16% |
+-------------------------------+----------------------------+------------------------------------+---------------------------+
| 13. | Price per share or value | 14. | Date and place of |
| | of transaction: | | transaction: |
| | GBP7.73 | | London, 24 November 2010 |
+-------------------------------+----------------------------+------------------------------------+---------------------------+
| 15. | Total holding following | 16. | Date issuer informed of |
| | notification and total | | transaction: |
| | percentage holding | | 30 November 2010 |
| | following notification | | |
| | (any treasury shares | | |
| | should not be taken into | | |
| | account when calculating | | |
| | percentage): | | |
| | 56,873,004 (29.4%) | | |
+-------------------------------+----------------------------+------------------------------------+---------------------------+
+-------------------------------+------------------------+---------------------------------+---------------------------+
| If a person discharging managerial responsibilities has been |
| granted options by the issuer complete the following boxes |
+----------------------------------------------------------------------------------------------------------------------+
| 17. | Date of grant | 18. | Period during which or |
| | | | date on which exercisable |
+-------------------------------+------------------------+---------------------------------+---------------------------+
| 19. | Total amount paid (if | 20. | Description of shares or |
| | any) for grant of the | | debentures involved |
| | option | | (class and number) |
+-------------------------------+------------------------+---------------------------------+---------------------------+
| 21. | Exercise price (if | 22. | Total number of shares or |
| | fixed at time of | | debentures over which |
| | grant) or indication | | options held following |
| | that price is to be | | notification |
| | fixed at the time of | | |
| | exercise | | |
+-------------------------------+------------------------+---------------------------------+---------------------------+
| 23. | Any additional | 24. | Name of contact and |
| | information | | telephone number for |
| | | | queries |
+-------------------------------+------------------------+---------------------------------+---------------------------+
+----------------------------------------------------------------+
| Name of authorised official or issuer responsible for making |
| notification |
| Henry Knowles, Company Secretary, Hikma Pharmaceuticals PLC |
+----------------------------------------------------------------+
| Date of notification: 1 December 2010 |
+----------------------------------------------------------------+
Notes:
This form is intended for use by an issuer to make a RIS notification required
by DTR 3.1.4
(1)An issuer making a notification in respect of a transaction relating to the
shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative
relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,
16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete boxes 1
to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBLBDDRBGBGGB
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
